These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 27529627

  • 1. C-Terminal to Intact Fibroblast Growth Factor 23 Ratio in Relation to Estimated Glomerular Filtration Rate in Elderly Population.
    Bożentowicz-Wikarek M, Owczarek A, Kocełak P, Olszanecka-Glinianowicz M, Więcek A, Chudek J.
    Kidney Blood Press Res; 2016; 41(5):519-526. PubMed ID: 27529627
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study.
    Lewerin C, Ljunggren Ö, Nilsson-Ehle H, Karlsson MK, Herlitz H, Lorentzon M, Ohlsson C, Mellström D.
    Bone; 2017 May; 98():1-8. PubMed ID: 28212898
    [Abstract] [Full Text] [Related]

  • 4. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
    van Breda F, Emans ME, van der Putten K, Braam B, van Ittersum FJ, Kraaijenhagen RJ, de Borst MH, Vervloet M, Gaillard CA.
    PLoS One; 2015 May; 10(6):e0128994. PubMed ID: 26079688
    [Abstract] [Full Text] [Related]

  • 5. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.
    Chudek J, Kocełak P, Owczarek A, Bożentowicz-Wikarek M, Mossakowska M, Olszanecka-Glinianowicz M, Wiecek A.
    Nephrol Dial Transplant; 2014 Sep; 29(9):1757-63. PubMed ID: 24729016
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.
    Hanudel MR, Wesseling-Perry K, Gales B, Ramos G, Campbell V, Ethridge K, Scotti M, Elashoff DA, Alejos J, Reemtsen B, Salusky IB.
    Pediatr Nephrol; 2016 Apr; 31(4):661-9. PubMed ID: 26525200
    [Abstract] [Full Text] [Related]

  • 8. Biological variability of plasma intact and C-terminal FGF23 measurements.
    Smith ER, Cai MM, McMahon LP, Holt SG.
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3357-65. PubMed ID: 22689697
    [Abstract] [Full Text] [Related]

  • 9. Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly.
    Holecki M, Chudek J, Owczarek A, Olszanecka-Glinianowicz M, Bożentowicz-Wikarek M, Duława J, Mossakowska M, Zdrojewski T, Skalska A, Więcek A.
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):900-9. PubMed ID: 25736796
    [Abstract] [Full Text] [Related]

  • 10. C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.
    Eisenga MF, van Londen M, Leaf DE, Nolte IM, Navis G, Bakker SJL, de Borst MH, Gaillard CAJM.
    J Am Soc Nephrol; 2017 Dec; 28(12):3639-3646. PubMed ID: 28774998
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Renal Clearance of Fibroblast Growth Factor-23 (FGF23) and its Fragments in Humans.
    Sharma S, Katz R, Ginsberg C, Bullen A, Vallon V, Thomson S, Moe OW, Hoofnagle AN, de Leeuw PW, Kroon AA, Houben AJHM, Ix JH.
    J Bone Miner Res; 2022 Jun; 37(6):1170-1178. PubMed ID: 35373859
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
    Marsell R, Grundberg E, Krajisnik T, Mallmin H, Karlsson M, Mellström D, Orwoll E, Ohlsson C, Jonsson KB, Ljunggren O, Larsson TE.
    Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826
    [Abstract] [Full Text] [Related]

  • 15. Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial.
    Stöhr R, Brandenburg VM, Heine GH, Maeder MT, Leibundgut G, Schuh A, Jeker U, Pfisterer M, Sanders-van Wijk S, Brunner-la Rocca HP.
    Eur J Heart Fail; 2020 Apr; 22(4):701-709. PubMed ID: 32020782
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.
    David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V, Zumbrennen-Bullough KB, Sun CC, Lin HY, Babitt JL, Wolf M.
    Kidney Int; 2016 Jan; 89(1):135-46. PubMed ID: 26535997
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interplay of erythropoietin, fibroblast growth factor 23, and erythroferrone in patients with hereditary hemolytic anemia.
    van Vuren AJ, Eisenga MF, van Straaten S, Glenthøj A, Gaillard CAJM, Bakker SJL, de Borst MH, van Wijk R, van Beers EJ.
    Blood Adv; 2020 Apr 28; 4(8):1678-1682. PubMed ID: 32324886
    [Abstract] [Full Text] [Related]

  • 20. The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans.
    Bielesz B, Reiter T, Hammerle FP, Winnicki W, Bojic M, Gleiss A, Kieweg H, Ratzinger F, Sunder-Plassmann G, Marculescu R.
    J Clin Med; 2020 Aug 14; 9(8):. PubMed ID: 32823844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.